3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
CNS
1
Conditions
Prostatic Neoplasms
11
Neoplasms
7
Carcinoma, Renal Cell
7
Kidney Neoplasms
5
Osteosarcoma
2
Neuroectodermal Tumors, Primitive
2
Medulloblastoma
2
Glioma
2
Wilms Tumor
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Multiple Myeloma
1
Meningioma
1
Interventions
Vincristine
16
Cyclophosphamide
16
Filgrastim
13
Etoposide
12
Doxorubicin
12
Radiotherapy
11
Carboplatin
10
X-Rays
9
Dactinomycin
9
Specimen Handling
8
Phantoms, Imaging
8
Magnetic Resonance Spectroscopy
8
Granulocyte Colony-Stimulating Factor
8
Temozolomide
6
Melphalan
6
Ifosfamide
6
Topotecan
5
Polymerase Chain Reaction
5
Peripheral Blood Stem Cell Transplantation
5
Nuclear Medicine Department, Hospital
5
Irinotecan
5
Busulfan
5
Biopsy
5
sargramostim
4
Stem Cell Transplantation
4
Gene Expression Profiling
4
Amplified Fragment Length Polymorphism Analysis
4
Thiotepa
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Thalidomide
×
Genitourinary
×
Clear all
NCT01661400
2024-01-31
ASCR
Washington University School of Medicine
Phase 1
Completed
14 enrolled